跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,688 条关于
“Cambrex Corporation”
全部
1,688
临床试验
154
药物
104
机构
474
资讯
956
去年
US Small Molecule API CDMO Market Projected to Reach $12.49 Billion by 2030 Driven by FDA Approvals and HPAPI Demand
2个月前
Small Molecule API Market to Reach $370.36 Billion by 2035, Driven by Oncology Demand and Manufacturing Innovation
去年
Cambrex Expands Peptide Manufacturing Capabilities with 20% Facility Growth in Massachusetts
24天前
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
去年
Geron Corporation Advances in Myeloid Hematologic Malignancies Treatment
去年
Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment
去年
PDS Biotech Updates Phase 3 VERSATILE-003 Trial Design for HPV16-Positive HNSCC
去年
Genelux Advances Olvi-Vec Trials in Lung and Ovarian Cancer, Anticipates Key Data Readouts
3年前
Geron's Imetelstat Shows Promise in MDS and Myelofibrosis Trials, NDA Submission on Track
去年
PDS Biotech's VERSATILE-003 Phase 3 Trial for HPV16-Positive Head and Neck Cancer to Initiate Q1 2025
第 1 页,共 96 页
上一页
下一页